Effectiveness and Tolerance of IV vs SC Biological Drugs in Gastrointestinal Diseases

Abroad (travel likely)Recruiting

Conditions

Inflammatory Bowel Diseases

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Fondazione Policlinico Universitario A. Gemelli IRCCS, UOC CEMAD, Roma, Italy
Contact: Study coordinator (Franco Scaldaferri) · franco.scaldaferri@policlinicogemelli.it · +390630156876
Contact: Principal Investigator (Franco Scaldaferri)

Study leads

Franco Scaldaferri, PI
Principal Investigator
Fondazione Policlinico Gemelli, Rome

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

FAecal Microbiota Transplantation in primaRy sclerosinG chOlangitis

Primary Sclerosing Cholangitis · Inflammatory Bowel Diseases

Abroad (travel likely)RecruitingPHASE2

Birmingham, United Kingdom · London, United Kingdom

Pilot and Feasibility Study of 2'-FL as a Dietary Supplement in IBD Patients Receiving Stable Maintenance Anti-TNF Therapy

Inflammatory Bowel Diseases · Crohn Disease · Ulcerative Colitis

Abroad (travel likely)RecruitingPHASE1, PHASE2

Hartford, United States · Cincinnati, United States

Effect of Acupuncture on Mild to Moderate Active Crohn's Disease

Intestinal Disorder · Inflammatory Bowel Diseases · Crohn Disease

Abroad (travel likely)Recruiting

Shanghai, China · Shanghai, China

Subcutaneous Infliximab After A Previous Intravenous Dose Optimization

Inflammatory Bowel Diseases · Crohn Disease · Ulcerative Colitis

Abroad (travel likely)RecruitingPHASE4

Ghent, Belgium · Ostend, Belgium